Dr. Eugene K. Cha

Dr. Eugene K. Cha, MD, is a urologic surgeon at Memorial Sloan Kettering Cancer Center with particular expertise in treating bladder cancer, kidney cancer, and prostate cancer. He has been caring for patients at MSK since 2015 and performs approximately 600 procedures each year. Dr. Cha specializes in minimally invasive surgical approaches for bladder cancer, kidney cancer, and upper urothelial cancers, including those arising in the renal pelvis and ureters. He is known for his commitment to ensuring that patients feel fully informed and confident in their treatment decisions, offering honest assessments of prognosis, clear explanations of available options, and thorough guidance on what to expect during recovery.

Dr. Cha takes a personalized approach to surgical care, working closely with each patient to weigh the risks and benefits of various treatment strategies in light of their individual preferences and circumstances. His research focuses on advancing care for patients with bladder cancer through clinical trials and outcomes-based studies. He serves as co-principal investigator of a trial evaluating targeted therapy for early-stage bladder cancer, and contributes to studies aimed at improving the surgical experience, recovery, and cancer outcomes for patients undergoing bladder removal. His team also analyzes the DNA mutation profiles of patients' tumors to identify eligibility for clinical trials and refine treatment planning.

Beyond the operating room, Dr. Cha is dedicated to fostering a supportive and hopeful environment for his patients, aiming to leave them feeling reassured and confident in the path forward. His work combines surgical precision, clinical research, and a deeply patient-centered philosophy to improve outcomes for people facing urologic cancers.